09-12, 12:15–12:45 (Europe/Istanbul), Young IFOS 2
The aim is to present an effective minimally invasive approach to the parapharyngeal space, particularly for the treatment of Eagle syndrome
Graduated in Medicine and Surgery in 2012 at the University of Brescia, BS, Italy.
Specialized in Otorhinolaryngology in 2017 under the supervision of Prof. Piero Nicolai, during which I carried out a research project at Mount Sinai Hospital, NY, USA.
After completing my residency, I worked at the National Cancer Institute in Milan, MI, Italy under the direction of Prof. Cesare Piazza.
I later moved to Trento, where I currently work as the head of the head and neck oncology group under the supervision of Prof. Ottavio Piccin.
Author and co-author of publications related to oncology, laryngectomy, and quality of life.
Andrés M. Bur, MD, FACS is the David S. Zamierowski Professor of Otolaryngology – Head and Neck Surgery and Vice Chair of Research at the University of Kansas. He earned his medical degree and completed residency training in Otolaryngology – Head and Neck Surgery at the University of Pennsylvania, followed by fellowship in Head and Neck Surgical Oncology and Microvascular Reconstructive Surgery at Emory University. As a fellowship-trained head and neck oncologic surgeon, his clinical practice focuses on complex oncologic resection and microvascular reconstruction, with particular expertise in transoral robotic surgery and free tissue transfer for advanced head and neck malignancies.
Dr. Bur’s research program centers on the development and clinical validation of biologically grounded artificial intelligence platforms for precision head and neck oncology. His work integrates radiomics, spatial transcriptomics, and machine learning to improve treatment response prediction, early cancer detection, and surgical decision-making in HNSCC. Through multi-institutional validation and translational radiogenomic studies linking imaging phenotypes to spatial tumor biology, his research advances a scalable, evidence-based framework for responsible AI implementation in cancer care. Supported by funding from the National Cancer Institute (NCI), National Institute of General Medical Sciences (NIGMS), National Institute on Aging (NIA), and the University of Kansas Cancer Center, Dr. Bur serves as Chair of the Young Members Service and Co-Chair of the Artificial Intelligence Task Force for the American Head and Neck Society. He is an invited national and international speaker on responsible clinical integration of artificial intelligence in otolaryngology and head and neck oncology.